Concepedia

Christine Vaupel

CV

8

Publications

910

Citations

8

H-Index

2015

Active since

Affiliations

Navidea Biopharmaceuticals (United States)(Current)

Vanderbilt University Medical Center

Vanderbilt University

University of South Florida

The University of Texas MD Anderson Cancer Center

Christine Vaupel is an author at Navidea Biopharmaceuticals (United States) specializing in medicine, pathology, and cancer research.

Top concepts

Publications per year

2015–2021

8

Publications

8

MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance

Brian Kwok, Jeff Hall, John S. Witte et al. · Blood · 2015 · 307 citations · Full text

Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes

David A. Sallman, Rami S. Komrokji, Christine Vaupel et al. · Leukemia · 2015 · 226 citations · Full text

, , +6

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti–PD-1 Therapies in Metastatic Melanoma

Douglas B. Johnson, Jennifer Bordeaux, Ju Young Kim et al. · Clinical Cancer Research · 2018 · 174 citations

, , +21

Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes

Wade T. Iams, Eileen Shiuan, Catherine B. Meador et al. · Journal of Thoracic Oncology · 2019 · 75 citations · Full text

PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program

Ling Li, Ruifang Sun, Yi Miao et al. · Modern Pathology · 2019 · 55 citations · Full text

, , +12

Rows per page

1–5 of 8